Cargando…
Low-dose subcutaneous immunoglobulin is an effective treatment for autoimmune bullous skin disorders: A case report
Intravenous immunoglobulin is a recognized treatment in recalcitrant autoimmune bullous diseases. Infusions are administered monthly over 1–5 days in the hospital setting and associated with mild to severe infusion-related systemic effects, in part due to the high doses necessary to induce and achie...
Autores principales: | Streu, Erin, Wiseman, Marni C, Johnston, James B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974749/ https://www.ncbi.nlm.nih.gov/pubmed/32010445 http://dx.doi.org/10.1177/2050313X19901071 |
Ejemplares similares
-
Blue-grey hyperpigmentation in acne after vandetanib therapy and doxycycline
use: A case report
por: Perlmutter, Jonah W, et al.
Publicado: (2022) -
Imiquimod-induced bullous pemphigoid: A case report
por: Li, Heidi Oi-Yee, et al.
Publicado: (2023) -
Annular bullous pemphigoid: A case report and review of literature
por: Arès, Steffie, et al.
Publicado: (2022) -
A case of radiotherapy-induced bullous pemphigoid with unusually delayed onset: A case report
por: El Barch, Maha, et al.
Publicado: (2023) -
A case of drug-induced bullous pemphigoid secondary to immunotherapy
treated with upadacitinib: A case report
por: Gresham, Louise M, et al.
Publicado: (2023)